Acelrx Pharmaceuticals reported $-342000 in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acelrx Pharmaceuticals ACRX:US $ -342000 890K
Baxter International BAX:US $ 1457M 107M
Becton, Dickinson and BDX:US $ 2067M 238M
Heron Therapeutics HRTX:US $ 12.1M 2.39M
Intra Cellular Therapies ITCI:US $ 31.84M 8.71M
Johnson & Johnson JNJ:US $ 16101M 273M
Pfizer PFE:US $ 19071M 3420M
Smiths SMIN:LN 456M 18M
Teva Pharmaceutical TEVA:IT 1.83B 26M
Xeris Pharmaceuticals Inc XERS:US $ 15.8M 740K